ACCEPT DECLINE
Change Visitor Type Sign up to our newsletter

Oxford Capital leads $2.5 million seed round – National MRI Scan

Oxford Capital leads $2.5 million seed round – National MRI Scan

By Oxford Capital |

The wait for diagnostic imaging is over: National MRI lands $2.5million from Monzo Founder and ex-Bupa CEO to get vital medical imaging done in a week

• The country faces record numbers of people waiting for diagnostic imaging with the number of people waiting more than three months for a scan being 22 times higher than in 2019.
• Waiting times for MRIs can now be cut from over six weeks to just seven days thanks to the platform’s proprietary technology, inevitably saving countless lives.
• The seed was co-led by Oxford Capital and YZR.

As the UK experiences record waiting times for diagnostic imaging, Digital Health startup, National MRI today announced its oversubscribed $2.5m seed led by Oxford Capital, YZR, Founders Factory, KM Capital and well-known industry angels Tom Blomfield, Evelyne Bourke (ex-BUPA CEO) and Harry Hurst (PIPE CEO).

With the country facing unprecedented waiting times for vital patient diagnostic testing, National MRI provides patients in the UK with quick, affordable diagnostic imaging services. Co-Founder and UK Managing Director, Jasper Nissim commented “It’s no secret that early diagnosis of many diseases, including cancer, leads to a better chance of survival. However, testing and diagnosis is a huge problem for the UK’s healthcare system, thanks to an insufficient number of CT and MRI scanners and record-breaking waiting times, worsened by the pandemic. 370,000 patients have waited 6+ weeks for one of 15 key diagnostic tests this August, which is a 780% increase since pre-pandemic (August, 2019).”

Founded in 2017 by Osteopath Jasper Nissim and Consultant Radiologist Khalid Latief, National MRI will use the funding to fuel its international expansion, launching in the USA and Germany under the SCAN.com brand name. The company is also working to build its B2B business model, targeting leading health insurance companies and new preventative services in the UK like FullBodyScan.com.

After bootstrapping to seven-digit revenue figures, the founding team, which also includes Charlie Bullock (CEO), Joe Daniels (Head of Front-End and UX) and Oliver Knight (COO), aims to make diagnostic imaging accessible and affordable to everyone around the world. National MRI allows patients to get a referral, pre consultation, scan, and post consultation in a week with a one-stop- shop platform.

Since launching in 2017 National MRI has grown to offer the largest number of private MRI scanners in the UK – with over 150 diagnostic centres nationwide on its platform. To date, over 20,000 patients have been scanned using National MRI. The platform presents an alternative solution to long NHS waitlists – relieving vital pressure on health service’s limited resources.

Commenting on the investment, lead investor Stephen Hampson, Investment Director, Oxford Capital added: “We’re proud to have backed National MRI at this early stage, there is a real need to transform healthcare services to address the long waiting times for those seeking a diagnosis or treatment. At Oxford Capital, we’re passionate about backing early stage companies in sectors in which the UK is considered a world leader and we’ve got a growing number of digital health companies in our portfolio. Co-founders Charlie and Oli and their team have already made huge strides to build the business and we’re looking forward to supporting them on their growth journey going forwards.”

Markus Feuerecker, Founding Partner YZR Capital also noted: “During our due diligence, the NMRI founding team demonstrated an excellent product and impressed us with their go-to-market speed and professional attitude, which is crucial in the healthcare market. As a Pan-European Health Tech focused firm with my Founding Partner colleague Prof. Dr. Reinhard Meier’s first-hand medical and telehealth expertise, we can effectively support NMRI on its growth journey. National MRI is an ideal match in terms of our common vision to improve the healthcare value chain, while creating social impact at the same time.”

National MRI is currently part of the Founders Factory accelerator program; where health insurance giant, Aviva, is the strategic partner for the FinTech sector. Henry Lane-Fox, CEO of Founders Factory added: “Our healthcare systems are reliant on having the right access to the right testing and tools but it is falling short of resources. National MRI is releasing some of the pressures on the NHS by enabling patients to book a scan at the widest selection of scanning centres at far lower prices than we’ve ever seen. They are changing the game by creating a platform that gets diagnostic testing and results done within a week, without breaking people’s purses. We’re thrilled to support this exciting digital health startup and help them scale”

 

Awards

  • BEST EIS
    FUND MANAGER
    2013,2012,2010 AND 2006

  • VENTURE CAPITAL
    HOUSE OF THE YEAR
    WINNER 2013 AND 2005

  • MOST IMPACTFUL
    INVESTMENT
    WINNER 2017

  • BEST ANGEL
    SYNDICATE
    WINNER 2018

  • BVCA Excellence in ESG
    GP CATEGORY
    COMMENDED 2020

  • VC INVESTOR OF THE YEAR
    GIANT HEALTH AWARDS
    WINNER 2020

  • EXIT OF THE YEAR
    ONE TO WATCH
    2020

  •            

    EXIT OF THE YEAR 2021 (FINALIST)UK BAA AWARDS